SCHEMBL4847248

SCHEMBL4847248

Cc1cc(C)cc(-c2ccc(OCCN(C)C)c(C=CC(=O)c3ccccc3Br)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.43
PTPN1 P18031 2/20 0.42
SYK P43405 2/20 0.41
MAOB P27338 1/20 0.41
AR P10275 2/20 0.40
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
HSP90AA1 P07900 1/20 0.39
MAPT P10636 1/20 0.39
ATM Q13315 1/20 0.39
KDM4E B2RXH2 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ESR1 P03372 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
HRH1 P35367 1/20 0.37
SLC6A9 P48067 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849810 0.91 ABCB1 (0.43) SYKMAOBARBCHEACHE
SCHEMBL4852546 0.89 SYK (0.44) HTR7PTPN1SYKARBCHE
SCHEMBL4847247 0.89 SYK (0.44) HTR7PTPN1SYKARBCHE
SCHEMBL4846881 0.89 MAOB (0.48) PTPN1MAOBARBCHEACHE
SCHEMBL4852423 0.88 SYK (0.43) SYKMAOBARBCHEACHE
SCHEMBL4849980 0.88 SLC6A9 (0.42) PTPN1SYKMAOBBCHEACHE
SCHEMBL14280886 0.88 SYK (0.43) SYKMAOBARBCHEACHE
SCHEMBL4849710 0.88 SYK (0.42) SYKARBCHEACHEALDH1A1
SCHEMBL4852988 0.87 HRH1 (0.41) PTPN1SYKMAOBARBCHE
SCHEMBL4853942 0.87 AR (0.45) SYKMAOBARBCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed